IXC

0.00%

6.6¢ invex therapeutics ltd

Yeah, I am comfortable with that due to 240 patients as opposed...

First 152 Last

Share
Profile

Follow
SSilverstein

795 Posts.

45

02/04/23

23:30

Post #: 67093881
Share

Originally posted by jellyroll: ↑

Agree with almost everything that you have said, other than the fact that this is a pretty big gamble, I would argue that the real gamble is in the asset "flavour" rather than in the specifics of the company or trial design. I think once one is prepared to take on a Phase III CNS risk, in a single asset development business, then this is about as low a risk as it it is possible to be, within that favour profile. Based on the history of all phase III trials involving generic drugs, statistically, we are looking at about an 80% chance of a positive outcome about 68% without a CRL and 80% after an initial CRL. My own view is that the risk of a CRL is lower than this base statistic given just how widely prescribed our API and the size of the effect that was seen in Phase II.

I have been thinking over the past few days about where the possible risks to this scenario might lie and I can really only come up with one "small" concern. Here I trust the experience of out CSO who will have significant experience in dealing with 100s of clinical cases and the Phase III trial uses the approach she uses in the clinic everyday. That concern relates the the change in method for the measurement of Intracranial Pressure between the Phase II and Phase III trial. You will recall that in the Phase II trial we implanted in to the patients skull pressure monitors that took tens of thousands of measuremets. However, in the Phase III trial we are using opening pressure at LP, obviously this is a lot less invasive but also a cruder method and we are taking just two measurements over the 24 weeks. However, given the size of the effect seen in the Phase II trials and the uniformity of the response and the fact this is how they measure ICP in the clinic then I am sufficently reassured .

Expand

Yeah, I am comfortable with that due to 240 patients as opposed to 16

IXC Price at posting: 43.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

There are more pages in this discussion • 90 more messages in this thread...

First 152 Last

Add IXC (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change 0.000(0.00%)		Mkt cap ! $4.960M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	100000	6.2¢

Sellers (Offers)

Price($)	Vol.	No.
6.8¢	10000	1

View Market Depth

No.	Vol.	Price($)
1	100000	0.062
1	15500	0.061
1	150000	0.060
1	100000	0.052
1	60001	0.041

Price($)	Vol.	No.
0.068	10000	1
0.069	16500	1
0.070	40000	1
0.076	888	1
0.083	4000	1

Last trade - 16.12pm 12/07/2024 (20 minute delay)

IXC (ASX) Chart

Day chart unavailable

Yeah, I am comfortable with that due to 240 patients as opposed...

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yeah, I am comfortable with that due to 240 patients as opposed...

Top Stories

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News